Daniel Markowitz
Stock Analyst at Evercore ISI Group
(3.17)
# 1,106
Out of 5,147 analysts
30
Total ratings
56.52%
Success rate
1.25%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Outperform | $250 → $260 | $208.04 | +24.98% | 3 | Feb 27, 2026 | |
| TMDX TransMedics Group | Maintains: Outperform | $155 → $170 | $145.26 | +17.03% | 2 | Feb 25, 2026 | |
| RGEN Repligen | Maintains: Outperform | $180 → $170 | $128.73 | +32.06% | 5 | Feb 25, 2026 | |
| GH Guardant Health | Maintains: In-Line | $105 → $110 | $93.90 | +17.15% | 4 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Outperform | $370 → $340 | $246.61 | +37.87% | 2 | Feb 19, 2026 | |
| TECH Bio-Techne | Maintains: In-Line | $62 → $68 | $59.00 | +15.25% | 4 | Feb 5, 2026 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $390 → $320 | $254.34 | +25.82% | 4 | Feb 3, 2026 | |
| RMBS Rambus | Maintains: Outperform | $126 → $119 | $99.66 | +19.41% | 3 | Feb 3, 2026 | |
| DXCM DexCom | Initiates: In-Line | $68 | $73.43 | -7.39% | 1 | Nov 25, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $150 → $125 | $64.51 | +93.77% | 2 | Oct 7, 2025 |
Natera
Feb 27, 2026
Maintains: Outperform
Price Target: $250 → $260
Current: $208.04
Upside: +24.98%
TransMedics Group
Feb 25, 2026
Maintains: Outperform
Price Target: $155 → $170
Current: $145.26
Upside: +17.03%
Repligen
Feb 25, 2026
Maintains: Outperform
Price Target: $180 → $170
Current: $128.73
Upside: +32.06%
Guardant Health
Feb 20, 2026
Maintains: In-Line
Price Target: $105 → $110
Current: $93.90
Upside: +17.15%
Insulet
Feb 19, 2026
Maintains: Outperform
Price Target: $370 → $340
Current: $246.61
Upside: +37.87%
Bio-Techne
Feb 5, 2026
Maintains: In-Line
Price Target: $62 → $68
Current: $59.00
Upside: +15.25%
West Pharmaceutical Services
Feb 3, 2026
Maintains: Outperform
Price Target: $390 → $320
Current: $254.34
Upside: +25.82%
Rambus
Feb 3, 2026
Maintains: Outperform
Price Target: $126 → $119
Current: $99.66
Upside: +19.41%
DexCom
Nov 25, 2025
Initiates: In-Line
Price Target: $68
Current: $73.43
Upside: -7.39%
Inspire Medical Systems
Oct 7, 2025
Maintains: Outperform
Price Target: $150 → $125
Current: $64.51
Upside: +93.77%